Perk Labs Statistics
Total Valuation
Perk Labs has a market cap or net worth of 3.68 million. The enterprise value is 3.96 million.
| Market Cap | 3.68M |
| Enterprise Value | 3.96M |
Important Dates
The last earnings date was Friday, July 25, 2025.
| Earnings Date | Jul 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 501.32M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +6.37% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 78.78 |
| PB Ratio | 1.09 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.69 |
| EV / Sales | 85.51 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.04, with a Debt / Equity ratio of 0.09.
| Current Ratio | 0.04 |
| Quick Ratio | 0.04 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -393.42 |
Financial Efficiency
Return on equity (ROE) is -76.63% and return on invested capital (ROIC) is -43.74%.
| Return on Equity (ROE) | -76.63% |
| Return on Assets (ROA) | -31.38% |
| Return on Invested Capital (ROIC) | -43.74% |
| Return on Capital Employed (ROCE) | -42.26% |
| Revenue Per Employee | 5,184 |
| Profits Per Employee | -163,842 |
| Employee Count | 9 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 15.85 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.63% in the last 52 weeks. The beta is -0.11, so Perk Labs's price volatility has been lower than the market average.
| Beta (5Y) | -0.11 |
| 52-Week Price Change | -98.63% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 47.62 |
| Average Volume (20 Days) | 6,102 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Perk Labs had revenue of 46,655 and -1.47 million in losses. Loss per share was -0.01.
| Revenue | 46,655 |
| Gross Profit | 3,311 |
| Operating Income | -1.48M |
| Pretax Income | -1.47M |
| Net Income | -1.47M |
| EBITDA | -1.53M |
| EBIT | -1.48M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 20,950 in cash and 308,385 in debt, giving a net cash position of -287,435.
| Cash & Cash Equivalents | 20,950 |
| Total Debt | 308,385 |
| Net Cash | -287,435 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 3.36M |
| Book Value Per Share | 0.01 |
| Working Capital | -1.57M |
Cash Flow
| Operating Cash Flow | -578,079 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 7.10% |
| Operating Margin | -3,163.91% |
| Pretax Margin | -3,160.59% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Perk Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -62.71% |
| Shareholder Yield | n/a |
| Earnings Yield | -40.12% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Perk Labs has an Altman Z-Score of -9.06 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -9.06 |
| Piotroski F-Score | 2 |